REDEFINING THE FUTURE OF CELL THERAPY WITH OUR AlloCAR T™ PRODUCT PLATFORM INNOVATION Multiplex gene-engineering and gene-editing capabilities Proprietary lymphodepletion platform State-of-the-art manufacturing Opportunity for product optimization SEE OUR PIONEERING PLATFORM >>…
CONTACT US Address 210 E. Grand Avenue South San Francisco, CA 94080 Phone 650-457-2700 General Information: HRops@allogene.com Investors Contact IR@allogene.com Media Contact media@allogene.com Job Inquiries: careers@allogene.com
COOKIE POLICY Please read this cookie policy for more details before giving your consent. You can prevent your data from being collected by Google Analytics on our Site by downloading…
A SHORT HISTORY OF AUTOLOGOUS CAR T THERAPY LEARN ABOUT AlloCAR T™ AUTOLOGOUS CAR T THERAPY Autologous chimeric antigen receptor (CAR) T cell therapy involves collecting a patient's white blood cells, including T cells, sending them to…
